Page last updated: 2024-08-26

bis(helenalinyl)malonate and Leukemia P388

bis(helenalinyl)malonate has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaney, SG; Hall, IH; Lee, KH; Liou, YF; Williams, WL1
Chaney, SG; Grippo, AA; Hall, IH; Holbrook, DJ; Lee, KH; Oswald, CB; Williams, WL1

Other Studies

2 other study(ies) available for bis(helenalinyl)malonate and Leukemia P388

ArticleYear
Investigation of sesquiterpene lactones as protein synthesis inhibitors of P-388 lymphocytic leukemia cells.
    Biochimica et biophysica acta, 1983, Mar-10, Volume: 739, Issue:2

    Topics: Animals; Antineoplastic Agents; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred DBA; Neoplasm Proteins; Poly U; Protein Biosynthesis; Sesquiterpenes; Sesquiterpenes, Guaiane; Terpenes

1983
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo.
    Journal of pharmaceutical sciences, 1988, Volume: 77, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; DNA, Neoplasm; IMP Dehydrogenase; In Vitro Techniques; Leukemia P388; Leukemia, Experimental; Male; Mice; Neoplasm Proteins; RNA, Neoplasm; Sesquiterpenes; Sesquiterpenes, Guaiane; Terpenes; Thioredoxins

1988